Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kronos Longevity Research Institute (KLRI) is a non-profit research organization focused on the study of human aging and the prevention of age-related diseases. Established in 1999 and headquartered in Phoenix, Arizona, the institute gained international recognition for leading the Kronos Early Estrogen Prevention Study (KEEPS), which investigated the timing of hormone therapy in menopausal women. KLRI's research portfolio emphasizes translational medicine, utilizing clinical trials to evaluate interventions such as hormone replacement and metabolic modulators. The organization has collaborated with numerous academic institutions and the National Institutes of Health to advance the science of longevity. While its primary operational phase has concluded, its findings continue to influence clinical guidelines for women's health and geriatric medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kronos Longevity Research Institute.